Refractory Tumors

Also known as: Refractory Tumor

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00531Cyclophosphamide1Active Not Recruiting1
DB16047Elraglusib1Active Not Recruiting1
DB00762Irinotecan1Active Not Recruiting1
DB09078Lenvatinib1Recruiting1
DB09035Nivolumab1Recruiting1
DB05578Ramucirumab1Completed1
DB00853Temozolomide1Active Not Recruiting1
DB00853Temozolomide1Completed1
DB01030Topotecan1Active Not Recruiting1
DB01030Topotecan1Completed1
DB06235Vadimezan1Completed1
DB06643Denosumab1 / 2Completed1
DB08916Afatinib2Recruiting1
DB11105Benzalkonium2Recruiting1
DB08875Cabozantinib2Recruiting1
DB08912Dabrafenib2Recruiting1
DB06423Endostatin2Recruiting1
DB00530Erlotinib2Recruiting1
DB01590Everolimus2Recruiting1
DB00317Gefitinib2Recruiting1
DB16630OPB-1110772Unknown Status1
DB09074Olaparib2Recruiting1
DB09567Olive oil2Unknown Status1
DB09073Palbociclib2Recruiting1
DB04900Thymalfasin2Recruiting1
DB00072Trastuzumab2Recruiting1
DB08881Vemurafenib2Recruiting1
DB11679FruquintinibNot AvailableCompleted1